Chenodeoxycholic Acid: Clinical Trials

3 trials of Chenodeoxycholic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1

Follow Chenodeoxycholic Acid: new trials by email Literature Review of Chenodeoxycholic Acid trials Research Report on Chenodeoxycholic Acid

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
Xenbilox, Resveratrol, Tahor - Spastic Paraplegia, Hereditary
Phase 2CompletedInstitut National de la Santé Et de la Recherche Médicale, France122015-01-082025-09-02
Cheno Effect on Transit in Health and IBS-C
Sodium chenodeoxycholate (NaCDC), Placebo - Constipation-predominant Irritable Bowel Syndrome
Phase 2CompletedMayo Clinic362009-04-012012-07-02
Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
chenodeoxycholic acid, lovastatin - Cerebrotendinous Xanthomatosis
Phase 2UnknownNational Center for Research Resources (NCRR)51996-01-012005-06-24

Conditions studied

Constipation (1)  ·  Ichthyosis Bullosa of Siemens (1)  ·  Metabolism, Inborn Errors (1)  ·  Paraplegia (1)  ·  Rare Diseases (1)  ·  Spastic Paraplegia, Hereditary (1)  ·  Xanthomatosis, Cerebrotendinous (1)

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  Mayo Clinic (1)  ·  National Center for Research Resources (NCRR) (1)

Countries

United States (2)  ·  France (1)

Top investigators

Michael L. Camilleri, M.D. (1)  ·  William Connor (1)

Results publications

PMID 20691689, PMID 29228183

NIH funding

1RC1DK086182 (1), R01DK054681 (1), R01DK079866 (1), UL1RR024150 (1)